New production and packaging lines from Romaco are designed to optimise the manufacture of effervescent products and blister packaging.
The pharmaceutical and healthcare contract manufacturer Aenova is investing around 20 million euros in its Bad Aibling site in order to significantly expand its production and packaging capacities. The site acts as a competence centre for blister packaging and for the production of effervescent products within the Aenova network. A new blister line was only put into operation in February 2025.
Increase in packaging performance
The state-of-the-art blister lines will increase the annual production capacity to 220 million blisters. This expansion is intended to further strengthen third-party packaging and increase the site's efficiency.
A new strip packaging line was also installed in the effervescent production area. This means that two strip lines and one tube line are now available for processing over 420 million effervescent tablets per year. Further investments are planned, including a new explosion-proof fluidised bed granulator for organic granulation.
„With these major investments, we can offer significantly increased production capacities on ultra-modern, fast systems and position ourselves as a preferred and strategic partner for our customers.“
Thomas Lemke, Managing Director of the Aenova site in Bad Aibling
The modernisation of the site offers shorter delivery times and greater capacity to respond flexibly to customer requirements, the company concludes.
Source: Aenova Group
